申请人:Kali-Chemie Pharma GmbH
公开号:US04649137A1
公开(公告)日:1987-03-10
New 2-acylaminomethyl-1H-2,3-dihydro-1,4-benzodiazepine compounds are described having the general formula I ##STR1## wherein R.sub.1 is a hydrogen atom or a lower alkyl or alkenyl radical or the cyclopropylmethyl radical, R.sub.2 is a hydrogen atom, n is 0, 1 or 2, R.sub.3 is an optionally substituted furyl, thienyl, pyrrolyl, pyridyl or phenyl radical, R.sub.4 is an optionally substituted furyl, thienyl or, pyrrolyl radical, R.sub.5 is a hydrogen or halogen atom, or a lower alkyl, lower alkoxy, hydroxyl, lower alkylthio, nitro, trifuloromethyl, cyano, amino, lower mono- or dialkylamino, lower monoalkanoylamino, lower N-alkyl-N-alkanoylamino or lower alkanoyloxy radical, and R.sub.6 is a hydrogen atom, or a lower alkyl or lower alkoxy radical or R.sub.5 and R.sub.6 together denote a methylenedioxy or ethylenedioxy radical. The compounds have pharmacological, for example, analgesic, properties.
本文描述了具有通式I的新型2-酰胺甲基-1H-2,3-二氢-1,4-苯二氮平化合物,其中R.sub.1是氢原子或低级烷基或烯基基团或
环丙基甲基基团,R.sub.2是氢原子,n为0、1或2,R.sub.3是可选的取代
呋喃基、
噻吩基、
吡咯基、
吡啶基或苯基基团,R.sub.4是可选的取代
呋喃基、
噻吩基或
吡咯基基团,R.sub.5是氢或卤原子,或低级烷基、低级烷氧基、羟基、低级烷
硫基、硝基、三
氟甲基、
氰基、
氨基、低级单烷基或二烷基
氨基、低级单烷酰胺基、低级N-烷基-N-酰胺基或低级酰氧基基团,R.sub.6是氢原子,或低级烷基或低级烷氧基基团或R.sub.5和R.sub.6一起表示亚甲二氧基或乙二氧基基团。这些化合物具有药理学性质,例如镇痛作用。